Literature DB >> 8339131

Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis.

M L Prevoo1, P L van Riel, M A van 't Hof, M H van Rijswijk, M A van Leeuwen, H H Kuper, L B van de Putte.   

Abstract

This prospective longitudinal study evaluates the validity and reliability of joint indices (JIs) used to measure disease activity in patients with RA. From seven traditional JIs (Ritchie Articular Index (RAI), Modified RAI, Thompson score, 28 JI, 36 JI, total tender and total swollen joints) 37 'new' JIs were computed by considering three different characteristics of joint inflammation, tenderness, swelling and the combination of tenderness and swelling, and by grading for tenderness and/or weighting for surface area of the joints. Several aspects of validity were investigated, the construct (correlation with radiographic damage), correlational (correlation with ESR, general health) and criterion validity (correlation with a Health Assessment Questionnaire, discrimination between high and low disease activity). It was found that the validity and reliability of traditional JIs do not differ substantially. Graded JIs are almost always more valid than ungraded JIs. Weighted JIs are almost always less valid and reliable than unweighted JIs. Therefore no JI proved to be superior for measuring the disease activity under consideration. Taking simplicity into account the 28 JI, not graded and not weighted, was preferable.

Entities:  

Mesh:

Year:  1993        PMID: 8339131     DOI: 10.1093/rheumatology/32.7.589

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  30 in total

Review 1.  Clinical outcome measures in rheumatoid arthritis.

Authors:  P L van Riel; A M van Gestel
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms.

Authors:  Victoria K Shanmugam; James McCloskey; Beth Elston; Sandra J Allison; Jennifer Eng-Wong
Journal:  Breast Cancer Res Treat       Date:  2011-11-11       Impact factor: 4.872

3.  Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency.

Authors:  Peter K Schädlich; Henning Zeidler; Angela Zink; Erika Gromnica-Ihle; Matthias Schneider; Christoph Straub; Josef G Brecht; Eduard Huppertz
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.

Authors:  C Carli; A G C Ehlin; L Klareskog; S Lindblad; S M Montgomery
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

5.  Evolving Use of Molecular Imaging in Research and in Practice.

Authors:  Ahmed Tawakol; Sebastian Unizony; Michael T Osborne; Elena Massarotti; Jon T Giles
Journal:  Arthritis Rheumatol       Date:  2019-08       Impact factor: 10.995

6.  Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis.

Authors:  Harald Mangge; Bernd Heinzl; Hans-Michael Grubbauer; Yosuf El-Shabrawi; Konrad Schauenstein
Journal:  Rheumatol Int       Date:  2003-04-10       Impact factor: 2.631

Review 7.  Induction therapy with combination TNF inhibitor and methotrexate in early rheumatoid arthritis.

Authors:  Yong Gil Hwang; Larry W Moreland
Journal:  Curr Rheumatol Rep       Date:  2014-05       Impact factor: 4.592

8.  3rd International Symposium on the Immunotherapy of the Rheumatic Diseases. 10-14 May 1995, Cyprus. Abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

9.  A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.

Authors:  S M M Verstappen; G A van Albada-Kuipers; J W J Bijlsma; A A M Blaauw; Y Schenk; H C M Haanen; J W G Jacobs
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

10.  The Nottingham Health Profile in rheumatoid arthritis: correlation with other health status measurements and clinical variables.

Authors:  F Sivas; O Erçin; O Tanyolaç; N Barça; S Aydoğ; K Ozoran
Journal:  Rheumatol Int       Date:  2003-08-27       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.